ClinicalTrials.gg
RecruitingNCT06804486DIScover_PedUpdated Oct 28, 2026

Exercise and Physical Activity in Children With Pediatric Acquired Brain Injury

An interventional study of Exercise and Recommendation to Deprescribe in Acquired Brain Injury, sponsored by Universidade da Coruña. Recruiting at 1 site in Spain. Open to participants aged 7 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Universidade da Coruña · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.
Updated Oct 28, 2026Now RecruitingSite recruiting status changed+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
7 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 43 studies in Brain Injuries with a site in Spain — 11 open to participants now, 13 under way, none of them phase 3. Brain Injuries · Spain.

Planned enrollment
20th of 30
25 · median 30
Started
2025
with 6 others
No phase
27 of 43
8 open now
Primary completion
2027-06
later than 7 of 12 live
Registered
33rd of 43
by date
Lead sponsor
4 of 43
Universidade da Coruña

Among the 43 studies in Brain Injuries with a site in Spain, this one is the 20th largest by planned enrollment of the 30 interventional ones that give a count, is one of 7 that started in 2025, is one of 27 with no phase, reaches primary completion later than 7 of the 12 other live ones, and was the 33rd registered.

Brain Injuries

947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.

Browse Brain Injuries studies →

Open to participants now

11 of the 43 studies in Brain Injuries with a site in Spain are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.

This study: 7 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 43 studies in Brain Injuries with a site in Spain, or all of them as a file.
02

Study summary

Exercise and physical activity in children with pediatric acquired brain injury

Read the detailed description

Although emerging approaches have emerged in the design of interventions that promote an orientation towards physical activity scientific evidence on their efficacy in this particular population remains limited. This underscores the need for further research to evaluate the efficacy of these intervention approaches in the context of pediatric ABI.

03

Conditions studied

  • Acquired Brain Injury

Keywords

  • PEDIATRIC ACQUIRED BRAIN INJURY
  • exercise
  • physical-sports activity
  • intervention
04

Who can participate

Ages eligible
7 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be under 18 years of age and present a medical diagnosis of pediatric acquired brain injury.
  • Have the completed and signed
  • Present a state that allows following indications for the practice of exercise and physical-sports activity.

Exclusion criteria

Exclusion Criteria:

  • Have medical comorbidities that contraindicate the safe performance of the program (i.e., cardiac or respiratory instability, uncontrolled seizures).
  • Have additional disabling conditions, such as cognitive impairment and/or an inability to communicate with the researcher verbally, in writing, or through an emissary.
  • Non-attendance and/or non-collaboration at 70% of the sessions of the program.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    active PEDIATRIC ACQUIRED BRAIN INJURY

    Behavioral: Exercise · Other: Recommendation to Deprescribe

  • No intervention
    non active PEDIATRIC ACQUIRED BRAIN INJURY

    non active PEDIATRIC ACQUIRED BRAIN INJURY

Interventions

  • BehavioralExercise

    Exercise and physical-sports activity program

    Also known as: exercise and physical-sports activity

  • OtherRecommendation to Deprescribe

    Recommendation to Deprescribe

06

What researchers measure

Primary outcomes

  1. Health-related Quality of Life

    Pediatric Quality of Life PedsQL

    Time frame: Through study completion, an average of 1 year

Secondary outcomes

  1. Functional state: Balance

    Berg Balance Scale and Timed Up and Go

    Time frame: Through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
  • Niño Jesus Hospital
    Madrid, Madrid 28040, Spain
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Jun 2027, 27 months after the start.

Of 285 non-industry interventional studies with no phase under Brain Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 27 months is close to that.

Counting every sponsor, half of 298 studies reached it within 24 months; a quarter within 12 and three quarters within 48.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 28, 2026: primary completion Feb 2026 → Jun 2027 and completion Feb 2026 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2025
First posted
Feb 3, 2025
StartActual
Mar 1, 2025
Primary completionEst.
Jun 28, 2027was Feb 2026
CompletionEst.
Jun 28, 2027was Feb 2026
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Recruiting
changed Oct 28, 2026
Sites
Niño Jesus Hospital is now Recruiting
Oct 28, 2026
Primary completion
Feb 28, 2026→Jun 28, 2027
Oct 28, 2026
Study completion
Feb 28, 2026→Jun 28, 2027
Oct 28, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedHealth-related Quality of LifeTime frame: Through study completion, an average of 1 year
Oct 28, 2026
Secondary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore FunctionalityNow Functional state: BalanceTime frame: Through study completion, an average of 1 year
Oct 28, 2026
Contact
Study contact now listed: added a•••@udc.es · •••2280. See the current contact
Oct 28, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Niño Jesus Hospital · Madrid, SpainContact added a•••@gmail.com · •••2280
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Active, not recruiting→Recruiting
    Niño Jesus Hospital is now Recruiting
    Primary completion Feb 28, 2026→Jun 28, 2027
    Study completion Feb 28, 2026→Jun 28, 2027
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedHealth-related Quality of LifeTime frame: Through study completion, an average of 1 year
    Secondary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore FunctionalityNow Functional state: BalanceTime frame: Through study completion, an average of 1 year
    Contact Study contact now listed: added a•••@udc.es · •••2280. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Niño Jesus Hospital · Madrid, SpainContact added a•••@gmail.com · •••2280
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06804486
Lead sponsor
Universidade da Coruña
Responsible party
Andrea Gutiérrez Suárez (PhD, Universidade da Coruña) — Principal investigator
First posted
Feb 3, 2025
Start date
Mar 1, 2025
Primary completion
Jun 28, 2027 (estimated)
Completion
Jun 28, 2027 (estimated)
Last update
Oct 28, 2026

Study contacts

Andrea Gutierrez, PhD
Contact
andrea.gutierrez@udc.es
+34 637592280

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion